News for Healthier Living

Inactivation of Key Pathway Boosts the Body's Immune Response Against Tumors

A study led by researchers from the University of Michigan showed that targeting CDK12 and a related gene, CDK13, strongly activates the stimulator of interferon genes, or STING, signaling pathway, enhancing the effectiveness of immunotherapies.

August 6, 2025


August 6 2025

August 5 2025

August 4 2025

August 3 2025

August 2 2025

August 1 2025

July 31 2025

July 30 2025

July 29 2025

July 28 2025

July 26 2025

July 25 2025

July 24 2025